Lexicon Pharmaceuticals, Inc.

D. E. Shaw & Co., Inc. LXRX

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/14/2026

Shares

22,200

Value ($000)

53

Weight

0.0%

2019 Q4 - 2026 Q2 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/14/2026	53	0.0%	22,200	6/30/2026
2025 Q2	8/14/2025	22	0.0%	23,723	6/30/2025
2023 Q4	2/14/2024	550	0.0%	359,210	12/31/2023
2023 Q3	11/14/2023	855	0.0%	784,122	9/30/2023
2023 Q2	8/14/2023	2,779	0.0%	1,213,726	6/30/2023
2023 Q1	5/15/2023	7,147	0.0%	2,940,997	3/31/2023
2022 Q4	2/14/2023	5,879	0.0%	3,077,973	12/31/2022
2022 Q3	11/14/2022	7,306	0.0%	3,043,977	9/30/2022
2022 Q2	8/15/2022	6,004	0.0%	3,228,072	6/30/2022
2022 Q1	5/16/2022	6,748	0.0%	3,228,704	3/31/2022
2021 Q4	2/14/2022	11,066	0.0%	2,808,428	12/31/2021
2021 Q3	11/15/2021	15,470	0.0%	3,216,048	9/30/2021
2021 Q2	8/16/2021	15,617	0.0%	3,402,425	6/30/2021
2021 Q1	5/17/2021	17,649	0.0%	3,006,612	3/31/2021
2020 Q4	2/16/2021	6,136	0.0%	1,794,009	12/31/2020
2020 Q3	11/16/2020	1,392	0.0%	966,607	9/30/2020
2020 Q2	8/14/2020	2,632	0.0%	1,319,151	6/30/2020
2020 Q1	5/15/2020	999	0.0%	512,412	3/31/2020
2019 Q4	2/14/2020	676	0.0%	162,971	12/31/2019